According to Zacks, “Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. “
Other research analysts have also issued reports about the stock. Jefferies Group reiterated a buy rating on shares of Lantheus Holdings in a report on Friday, August 5th. Credit Suisse Group AG set a $4.00 price objective on shares of Lantheus Holdings and gave the stock a hold rating in a report on Friday, August 5th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Lantheus Holdings has an average rating of Hold and a consensus target price of $7.40.
Lantheus Holdings (NASDAQ:LNTH) opened at 8.23 on Wednesday. Lantheus Holdings has a 52 week low of $1.76 and a 52 week high of $10.10. The company has a 50-day moving average of $8.40 and a 200-day moving average of $4.40. The stock has a market cap of $250.08 million, a P/E ratio of 9.29 and a beta of 0.45.
Lantheus Holdings (NASDAQ:LNTH) last released its earnings results on Thursday, August 4th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.06 by $0.18. The company had revenue of $78 million for the quarter, compared to analyst estimates of $72.66 million. Lantheus Holdings had a net margin of 9.00% and a negative return on equity of 11.75%. On average, analysts predict that Lantheus Holdings will post $0.55 EPS for the current fiscal year.
Hedge funds have recently bought and sold shares of the company. Brigade Capital Management LP acquired a new stake in Lantheus Holdings during the second quarter worth about $5,219,000. Globeflex Capital L P acquired a new stake in Lantheus Holdings during the second quarter worth about $1,410,000. Spark Investment Management LLC increased its stake in Lantheus Holdings by 541.2% in the first quarter. Spark Investment Management LLC now owns 106,100 shares of the company’s stock worth $200,000 after buying an additional 89,553 shares during the period. Paloma Partners Management Co acquired a new stake in Lantheus Holdings during the second quarter worth about $179,000. Finally, Oxford Asset Management acquired a new stake in Lantheus Holdings during the second quarter worth about $158,000. 30.15% of the stock is owned by hedge funds and other institutional investors.
About Lantheus Holdings
Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.